Lucid Diagnostics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $54.7M | $53.7M |
| FY2022 | — | $23.0M | $22.5M |
| FY2023 | — | $-2.3M | $18.9M |
| FY2024 | — | $5.4M | $22.4M |
| FY2025 | — | $10.9M | — |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $54.7M | $53.7M |
| FY2022 | — | $23.0M | $22.5M |
| FY2023 | — | $-2.3M | $18.9M |
| FY2024 | — | $5.4M | $22.4M |
| FY2025 | — | $10.9M | — |